Literature DB >> 2010159

Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry data. The Danish Association for the Study of the Liver.

T P Almdal1, T I Sørensen.   

Abstract

The sex-specific and age-specific incidence rates of the major parenchymal liver diseases in a North European population were estimated using a computerized registry of all admissions to somatic hospitals in Denmark. The incidence was calculated by counting all incident cases of these diseases reported to the registry in the 5-yr period 1981 to 1985 and dividing the number of cases by the number of person-years at risk in this period. The incidence rates (per million person-years) were for men and women, respectively: infectious hepatitis, 109 and 71; toxic hepatitis, 19 and 22; chronic hepatitis, 27 and 29; alcoholic cirrhosis, 190 and 85; nonalcoholic nonbiliary cirrhosis, 110 and 82; primary biliary cirrhosis, 4 and 14. The pattern of the age-specific incidence rates was similar in men and women in infectious hepatitis, alcoholic cirrhosis, nonalcoholic nonbiliary cirrhosis and primary biliary cirrhosis. Toxic and chronic hepatitis had a higher incidence in women than in men only in older age groups. The incidence of idiopathic hemochromatosis, Wilson's disease, secondary biliary cirrhosis, portal vein thrombosis and Budd-Chiari's syndrome were less than four in both sexes.

Entities:  

Mesh:

Year:  1991        PMID: 2010159

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  27 in total

Review 1.  Splanchnic vein thrombosis: clinical presentation, risk factors and treatment.

Authors:  Valerio De Stefano; Ida Martinelli
Journal:  Intern Emerg Med       Date:  2010-06-08       Impact factor: 3.397

Review 2.  Drug dosage in the elderly: dermatological drugs.

Authors:  Anna Flammiger; Howard Maibach
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

3.  Primary biliary cirrhosis: epidemiology helping the clinician.

Authors:  J V Metcalf; D Howel; O F James; R Bhopal
Journal:  BMJ       Date:  1996-05-11

4.  Increased risk and case fatality rate of pyogenic liver abscess in patients with liver cirrhosis: a nationwide study in Denmark.

Authors:  I Mølle; A M Thulstrup; H Vilstrup; H T Sørensen
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

5.  When the entire population is the sample: strengths and limitations in register-based epidemiology.

Authors:  Lau Caspar Thygesen; Annette Kjær Ersbøll
Journal:  Eur J Epidemiol       Date:  2014-01-10       Impact factor: 8.082

6.  Data quality of administratively collected hospital discharge data for liver cirrhosis epidemiology.

Authors:  K Vestberg; A M Thulstrup; H T Sørensen; P Ottesen; S Sabroe; H Vilstrup
Journal:  J Med Syst       Date:  1997-02       Impact factor: 4.460

Review 7.  Managing unusual presentations of venous thromboembolism.

Authors:  Walter Ageno
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

8.  The natural history of histologically proved drug induced liver disease.

Authors:  P G Aithal; C P Day
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

9.  Treatment of Budd-Chiari syndrome with a focus on transjugular intrahepatic portosystemic shunt.

Authors:  Anders Bay Neumann; Stine Degn Andersen; Dennis Tønner Nielsen; Peter Holland-Fischer; Hendrik Vilstrup; Henning Grønbæk
Journal:  World J Hepatol       Date:  2013-01-27

10.  The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study.

Authors:  Peter Jepsen; Hendrik Vilstrup; Peter Ott; Susanne Keiding; Per K Andersen; Niels Tygstrup
Journal:  BMC Gastroenterol       Date:  2009-06-30       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.